- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe active granulomatosis with polyangiitis (GPA) and severe active microscopic polyangiitis (MPA)
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 910KB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 503KB)
Avacopan – July 2023
Avacopan: Capsule 10 mg; Tavneos® - July 2023
Last updated
10 November 2023